UK–US Arrangement — Relevance to Wales

The NICE threshold increase from April 2026 applies to NHS Wales, which follows NICE technology appraisals automatically. Nine additional medicines approved under the new threshold since April will require Blueteq forms to be created and activated for the Welsh deployment. The fast-track pilots announced by DHSC on 2 July are England-specific; AWMSG continues to assess […]

SMC Decisions — 13 July 2026

SMC Decisions — 13 July 2026 The Scottish Medicines Consortium published advice on six medicines on 13 July 2026. Five, which appear to be high cost drugs, were accepted. (Fezolinetant list price in the UK has not been confirmed publicly, but comparable products in the US cost approximately $10,000–15,000 per year. It is accepted within […]